Skip to main navigation
Skip to search
Skip to main content
Luxembourg Institute of Health Home
Search content at Luxembourg Institute of Health
Home
Profiles
Research units
Research output
Projects
Equipment
Datasets
A 4-miRNA signature predicts the therapeutic outcome of glioblastoma
Maximilian Niyazi
, Adriana Pitea
, Michel Mittelbronn
, Joachim Steinbach
, Carsten Sticht
, Franz Zehentmayr
, Daniel Piehlmaier
, Horst Zitzelsberger
, Ute Ganswindt
, Claus Rödel
, Kirsten Lauber
, Claus Belka
, Kristian Unger
*
*
Corresponding author for this work
Research output
:
Contribution to journal
›
Article
›
Research
›
peer-review
38
Citations (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'A 4-miRNA signature predicts the therapeutic outcome of glioblastoma'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Axon Guidance Pathway
14%
Combined Modality Therapy
14%
Correlation Approach
14%
Cox Proportional Hazards
14%
Diagnostic Tool
14%
Extracellular Matrix Deposition
14%
FFPE Sections
14%
Glioblastoma
100%
Glioma Patients
42%
Hazard Coefficient
14%
Hazard Ratio
14%
Immune Response
14%
Inter-individual Variability
14%
Median Survival
14%
Methylation Age
14%
MGMT Promoter Methylation
14%
Microarray Data
14%
MicroRNA
100%
Overall Survival
14%
Path Analysis
28%
Patient Identification
14%
Poor Prognosis
14%
Prognostic Groups
14%
Quantitative PCR
14%
Risk Score
28%
Score-based
14%
Signature Recognition
14%
Standard of Care
14%
Therapeutic Efficacy
100%
Treatment Outcome
14%
Treatment Strategy
14%
Tumorigenesis
14%
Immunology and Microbiology
Axon Guidance
100%
Extracellular Matrix
100%
Immune Response
100%
Methylation
100%
Overall Survival
100%
Promoter Region
100%
Quantitative Reverse Transcription Polymerase Chain Reaction
100%
Biochemistry, Genetics and Molecular Biology
Axon Guidance
20%
Carcinogenesis
20%
G Protein Coupled Receptor
20%
Immune Response
20%
Methylation
20%
Microarray Data
20%
MicroRNA
100%
Overall Survival
20%
Promoter Region
20%
Quantitative Reverse Transcription Polymerase Chain Reaction
20%